A detailed history of Cpmg Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Cpmg Inc holds 5,328,867 shares of PRCT stock, worth $354 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
5,328,867
Previous 5,328,867 -0.0%
Holding current value
$354 Million
Previous $223 Million 17.92%
% of portfolio
100.0%
Previous 100.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$38.78 - $46.78 $145 Million - $174 Million
-3,726,474 Reduced 41.15%
5,328,867 $221 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $57.6 Million - $94.4 Million
-1,863,052 Reduced 17.06%
9,055,341 $375 Million
Q1 2022

May 16, 2022

SELL
$16.89 - $35.74 $5.14 Million - $10.9 Million
-304,269 Reduced 2.71%
10,918,393 $382 Million
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $403 Million - $471 Million
11,222,662 New
11,222,662 $428 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.96B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Cpmg Inc Portfolio

Follow Cpmg Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpmg Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cpmg Inc with notifications on news.